13/06/2026
NGI, in collaboration with Hillgene and Naleya Hillgene Inovasi (NHI), is proud to announce our participation in the 1st Asia Pacific Regenerative Medicine Congress (APREMIC) 2026 through an exclusive workshop:
“Accelerating Advanced Cell Therapies: Strategic Approaches to CMC and Global Development”
Gain valuable insights into the latest applications and strategies of multi-omics in cell therapy, global development pathways, and clinical decision-making through expert-led presentations, interactive case discussions, and hands-on learning sessions.
Our expert, Dr. Dan Zhang, Co-Founder and Co-CEO of Hillgene, will share valuable insights on “International Perspectives on Research and Development Strategies for Cell Therapies.”
In addition, Karin Yo, Product Manager of BGI Genomics, will present “Integrated Application of Multi-Omics Precision Diagnostics Throughout the Entire Lifecycle of Cell Therapy.”
Date: 2 July 2026
Time: 08:00 – 12:00 WIB
Venue: Grand Hyatt Jakarta
Whether you are a clinician, researcher, or healthcare professional, this workshop offers a unique opportunity to deepen your knowledge, exchange ideas with industry experts, and stay at the forefront of regenerative medicine.
Register and secure your seat here:
https://www.inasrm.com/